TAMBE Japan Post-Marketing Surveillance

Not yet recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

February 28, 2034

Study Completion Date

February 28, 2034

Conditions
Thoracoabdominal Aortic AneurysmPararenal Aortic Aneurysm
Interventions
DEVICE

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis

The target patients are those who were attempted to implant the AC during the enrollment period of this surveillance. Patients will also be targeted even if all components of the TAMBE device (devices that can be used in combination with AC specified in IFU) were not used, or if a device other than the component of the TAMBE device was used.

All Listed Sponsors
collaborator

CMIC Co, Ltd. Japan

INDUSTRY

lead

W.L.Gore & Associates

INDUSTRY

NCT07147569 - TAMBE Japan Post-Marketing Surveillance | Biotech Hunter | Biotech Hunter